×
Back to Agenda
S15 : How ICH E17 Enables East Asian Countries to Change Their Development Strategies in Simultaneous Development?
Session Chair(s)
Hideharu Yamamoto, PHD
Chairperson Data Science Expert Committee Drug Evaluation Committee, Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Nobushige Matsuoka, PHD
Group Lead, Clinical Statistics Group 2, Biometrics & Data Management, Pfizer R&D Japan G.K., Japan
Annie Xu
China Biostatistician Lead,BQS East Asia, UCB China, China
Kei Watabe
Senior Director, Biostatistics, Sumitomo Pharma Co., Ltd., Japan
Yasuto Otsubo
Review Director, Office of New Drug II , Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Guohua (James) Pan, PHD
China Head of Statistics and Decision Sciences, Janssen China R&D Center, China
Have an account?